humira - adalimumab
(Adalimumab)Abbvie Inc.
Usage: HUMIRA is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, juvenile idiopathic arthritis, and non-infectious uveitis in adults and eligible pediatric patients.